S100A4 and hepatocellular carcinoma: In this study, we aim to verify the future diagnostic and therapeutic applications of TGFβI and S100A4 in HCC by analysing the evaluation effect of TGFβI plus S100A4 on the progression of HCC and their influence on ferroptosis in HCC, thereby providing references for clinical practice and subsequent research.